Clinical Trials › NCT02659956
Recruiting
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
Sponsored by National Institute of Neurological Disorders and Stroke (NINDS)
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 250
Target enrollment
1
U.S. states
Apr 2016
Start date
Feb 2080
Expected completion
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Maryland1 site
Bethesda
MS centers in Maryland
Compare treatment centers near a trial site by center type, providers and trials.
View Maryland centers